Sodium nitroprusside (SNP) is frequently used as an hypotensive agent for clipping of intracranial aneurysms, repair of arteriovenous malformations and resection of vascular tumours. Cyanide (CN), which is its main metabolic product, has been recovered from the cerebrospinal fluid (CSF) of the rat after intravenous administration of CN, but recovery of CN from CSF after SNP has not been reported in man.
cerebrospinal fluid (CSF) of the rat after intravenous CN administration and may damage the brain cells sufficiently to cause encephalopathy as a result of histotoxic anoxia. 3 '4 We have previously shown progressive increase in red cell and plasma cyanide concentration when SNP was administered continuously, but recovery of CN from CSF after SNP infusion in man has not been reported.
METHOD
Seven consenting adults, classified for surgery as ASA II, were scheduled for induced hypotension for clipping of aneurysms or ligation of arteriovenous malformation. All were premedicated with pentobarbitone 2 mg'kg -t and atropine 0.4 mg one hour before induction of anaesthesia. Anaesthesia was induced with thiopentone 8 mg.kg -1 and maintained with nitrous oxide 60 per cent with oxygen and 0.05 mg supplements of fentanyl as needed. Pancuronium 0.l mg-kg -t 228 was given intravenously to facilitate tracheal intubation and to provide muscle relaxation. Radial artery, central venous and Foley urinary catheters were inserted. A soft Portex | catheter was introduced into the subarachnoid space through a -,#17 Tuohy needle for CSF drainage and CSF CN determination. Arterial carbon dioxide (Paco2) was maintained between 4.5-5.3 kPa (34-40 tort) with an Air Shields Ventilator 9 SNP (0.01% solution) was given by continuous intravenous infusion at a rate sufficient to reduce arterial pressure to two-thirds of the preoperative systolic level. Blood and CSF samples obtained simultaneously before, 15 minutes and subsequently at 30 minute intervals up to 240 minutes after starting SNP were analyzed for CN using a specific ion electrode calibrated by plotting a digital ionanalyzer standard CN solutions (10 -2, 10 -4, l0 -16, 10 -32) against the log of the CN concentration. Blood and CSF CN concentration were then determined by referring the rnillivolt electrode potential of the Digital lonanalyzer to the standardized response curve. CSF CN was not calculated after 18 hours. (Table I) . 
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sion in man. 
DISCUSSION
CN is a small molecule (molecular weight 26) which can diffuse across membranes and transfer from plasma to CSF across the blood-brain barrier. The possible crossing sites include the choroid plexus, the arachnoid membrane overlying the subarachnoid space, and brain extracellular space. CN may also enter the CSF by an excretory "sink" action of CSF which extracts CN from the brain, s Anoxic brain damage in experimental animals exposed to CN results from inhibition of cytochrome oxidase. 3 Differential sensitivity to brain injury may be due to local variations in metabolic demand. White matter (callosum and striatum) has a lower cytochrome oxidase concentration than gray and is therefore more sensitive to CN, although gray matter injury can also occur following exposure to high concentration of CN or exposure to low concentration for long periods. Ischaemic areas of brain are more sensitive to CN induced anoxia. 6 Autoregulation and collateral circulation normally allow for compensatory increase of flow in response to moderate hypoxia or ischaemia. Unilateral carotid artery ligation, for example, does not result in brain injury if autoregulation and collateral circulation are intact, but if a normally innocuous dose of cyanide is administered during the period of ligation, brain damage will occur. 3 Calculating the maximum amount of CN which can be originated for each milligram of SNP, we found that only 17 per cent was recovered from plasma red cells, leaving 83 per cent for metabolic interference by binding the cytochrome oxidase system. Direct contact of CN with brain tissue in animals results in depression of oxidative metabolism.
In patients with disrupted cerebral autoregulation SNP should be administered carefully and attention paid to the fact that CN crosses the blood-brain barrier and can be recovered in CSF. We do not know the effect of CSF CN on recovery of our patients. However, two of our patients who received more than 1 mg. kg -I SNP recovered slowly despite adequate reversal with naloxone.
How much of this postanaesthetic brain depression is due to CSF CN is not known. We postulate, however, that high concentrations of CN in CSF can produce a histotoxic hypoxia in patients with an abnormal blood-brain barrier and especially in those with increased intracranial pressure and decreased cerebral perfusion pressure who may develop tachyphylaxis to SNP.
CONCLUSION
CN resulting from degradation of SN P crosses the blood-brain barrier in patients with intracranial neurovascular disorders. Despite control of blood pressure, CN recovery from CSF warrants cautious administration.
Cytotoxic cerebral oedema and CN encephalopathy have been reported in animal studies after intravenous injection of sodium thiocyanate and concommitant ischaemia has been shown to 231 precipitate the development of early encephalopathy in rats. The dose of SNP administered to a patient with impaired autoregulation or with decreased intracerebral collateral circulation should probably be less than 0.7 mg' kg -I acutely administered.
RESUMI~
Le nitroprusside de sodium est I'agent hypotenseur par excellence utilis~ au cours des interventions intracranienne telles que malformation art6rio-veineuse, excision de tumeur vasculaire, r6paration d'an~vrysmes c6rebraux. Le cyanure, principal m~tabolite du SNP a 6t6 retrouv6 dans le liquide c~phalo-rachidien du rat apr~:s administration intraveineuse de thiocyanate de sodium. Aussi une ~tude a 6t~ entreprise sur sept volontaires en rue de d6terminer la quantit6 de cyanure pr~sente dans le LCR de I'homme ~ la suite d'une injection intraveineuse de la substance susmentionn~e (SNP).
Ces patients ont re~u pentobarbitone 2 mg-kg -t et atropine 0.4 rag, une heure avant l'intervention chirurgicale. L'induction anesthesique a ~t~ r~alis~e au thiopentone 8 rag-kg -~ et au protoxyde d'azote 60 pour cent. Du fentanyl et du pancuronium ont ~t6 ajout~s au besoin. Des catheters ont ete places, respectivement dans le canal rachidien, l'oreillette droite et I'art~re radiale. La Pco 2 a ~t6 maintenue entre 4.66 et 5.32 kPa (35 et 40 torr) pendant toute la dur~e de l'intervention. La quantit~ de cyanure contenue clans le plasma, les globules rouges et le LCR a 6t6 calcul~e h I'aide d'un ionisateur digital h des intervalles de 30 minutes apr~s I'injection de SNP. La pression arterielle de ces patients a 6t6 r~duite aux 2/3 de la valeur trouv~e avant I'op6ration. Pour une dose moyenne de 0.51 mg. kg-t de SNP injectS, la concentration de cyanure retrouvee dans les globules rouges passait de 9.5 -+ 2.05 ~t 75.12 -17.12. Au niveau du plasma cette concentration s'6tait ~lev~e de 0.54 -0.05 h 1.09 0.14/~g pour cent. Dans le LCR, le cyanure atteignait une concentration de 0. I 1 -0.4 ~ 0.72 ---0.07/xg pour cent.
Une augmentation considerable du cyanure dans les globules rouges, le plasma et le LCR a donc ~t~ observ6e 45 minutes apr~:s l'administration de SNP par voie intraveineuse chez rhomme, augmentation qui n'~tait plus notee 19 heures apr~s I'injection.
Conclusion
Le cyanure traverse la barri~re sanguine r et son administration b. dose 61ev~e sous forme de SNP exige une attention sp~eiale chez les patients pr6sentant des troubles dans le fonctionnement de cette barriO:re. I1 est ~ noter que des complications s~rieuses telles que l'oed~me c~rgbral et I'enc6phalopathie ont 6tg enregistr6s chez le rat.
